by Anish Dhanarajan | May 17, 2024 | Blog
Numerous potential compounds in pharmaceutical development are categorized under BCS classification III and IV. These compounds exhibit poor bioavailability due to their low permeability across biological membranes. These includes hydrophilic small molecules, which do...
by Anish Dhanarajan | May 15, 2024 | Blog
A large number of promising compounds in the pharmaceutical pipelines fall under BCS classification III and IV that show poor bioavailability due to low permeability across biological membranes. Often the only option for safe and effective delivery for these...